A study of 6522 patients found that 24 (0.4%) had experienced adverse reactions, the most frequent being anorexia, nausea, vomiting, and rash [29]
Arthritis: This is a general term for many conditions that cause stiffness and swelling in your joints
Petrillo S, DAmico J, La Rosa P, Bertini ES, Piemonte F (2019) Targeting NRF2 for the treatment of Friedreichs ataxia: a comparison among drugs
In 2013, the FDA issued a safety warning about unpublished findings linking GLP-1 drugs, also called incretin mimetics, to pancreatitis and pre-cancerous cells in the pancreas
It wasn't until 2023 that the FDA issued a Black Box warning for potential risks of thyroid cancer along with several mandated label warnings that highlighted a potential risk for kidney failure and pancreatitis when taking Ozempic
Related article: Diabetes risk factors Ischaemic optic neuropathy: A 2026 study looked at FDA adverse event reporting from 2017 2024 for GLP-1 medications